| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/10/2013 | WO2013040502A3 Processes and kits to detect and monitor for diagnostic biomarkers for post traumatic stress disorder (ptsd) and to differentiate between suicidal and non-suicidal form of the disorder |
| 05/10/2013 | WO2013040436A3 Esx-mediated transcription modulators and related methods |
| 05/10/2013 | WO2013040391A3 Novel surface markers for adipose tissues |
| 05/10/2013 | WO2013040358A3 Assays and compositions for detection of agr2 |
| 05/10/2013 | WO2013040300A3 System and method for support of medical diagnosis |
| 05/10/2013 | WO2013040078A3 Engineered tissues for in vitro research uses, arrays thereof, and methods of making the same |
| 05/10/2013 | WO2013040071A3 Sperm protein as a detection biomarker of early stage ovarian cancer |
| 05/10/2013 | WO2013038016A3 Monoclonal antibodies for detection of high-risk human papillomavirus oncoprotein e7 |
| 05/10/2013 | WO2013036936A9 Microrna biomarkers for diagnosing parkinson's disease |
| 05/10/2013 | WO2013036515A3 Pore parameters and hydraulic parameters from electric impedance spectra |
| 05/10/2013 | WO2013036064A3 Method for measuring concentration of proteins in cytoplasm solution |
| 05/10/2013 | WO2013023198A3 Rapid and sensitive detection of bacteria in blood products, urine, and other fluids |
| 05/10/2013 | WO2013022953A3 Biomarker for alzheimer's disease and/or mild cognitively impairment, and use thereof |
| 05/10/2013 | WO2013019655A3 Vimentin as a biomarker for the progression of myeloproliferative neoplasms |
| 05/10/2013 | WO2013009655A3 Uses of labeled hsp90 inhibitors |
| 05/10/2013 | WO2013009106A3 Method and apparatus for measuring a residual chloride concentration using a sensor, and water treatment system using the method and apparatus |
| 05/10/2013 | WO2013003849A3 Process and apparatus for quantifying nucleic acid in a sample |
| 05/10/2013 | WO2013001507A3 Treatment planning based on polypeptide radiotoxicity serum markers |
| 05/10/2013 | WO2012177647A3 Mycotoxin diagnostics and methods thereof |
| 05/10/2013 | WO2012170993A3 Assays and methods pertaining to pre-amyloid intermediates |
| 05/10/2013 | WO2012162701A4 Oil detection process, apparatus and taggant therefor |
| 05/10/2013 | WO2012153187A4 Markers for cancer prognosis and therapy and methods of use |
| 05/10/2013 | WO2012143692A3 Processing system and method |
| 05/10/2013 | WO2012123936A3 Devices and methods for real time detection of chemical and biological gaseous hazards |
| 05/10/2013 | WO2012059743A2 Temperature calibration methods and apparatus for optical absorption gas sensors, and optical absorption gas sensors thereby calibrated |
| 05/10/2013 | WO2010125566A3 Markers for cancer detection |
| 05/10/2013 | CA2854555A1 Assay for predictive biomarkers of anti-estrogen efficacy |
| 05/10/2013 | CA2854459A1 Novel chemistry used in biosensors |
| 05/10/2013 | CA2854432A1 Fluorescence immunoassay using polypeptide complex containing fluoro-labeled antibody variable region |
| 05/10/2013 | CA2854322A1 System and method for the analysis of biodiesel |
| 05/10/2013 | CA2854131A1 Use of an anti-.alpha.-synuclein antibody to diagnose an elevated level of .alpha.-synuclein in the brain |
| 05/10/2013 | CA2854059A1 Diagnostic and treatment of an androgen-independent prostate cancer |
| 05/10/2013 | CA2853962A1 Temperature calibration methods and apparatus for optical absorption gas sensors, and optical absorption gas sensors thereby calibrated |
| 05/10/2013 | CA2853668A1 Formation tester interval pressure transient test and apparatus |
| 05/10/2013 | CA2853665A1 Methods and materials for modulating start-up time and air removal in dry sensors |
| 05/10/2013 | CA2853464A1 Undifferentiated cell detection method and complex carbohydrate detection method |
| 05/10/2013 | CA2853292A1 Transgenic pig models of cystic fibrosis |
| 05/10/2013 | CA2852811A1 Adam22 for use as a prognostic variable, and target for therapy, of a metastatic breast cancer disease |
| 05/10/2013 | CA2851540A1 Peptides and methods for the detection of lyme disease antibodies |
| 05/10/2013 | CA2850689A1 Hand-held analytical device and method for its operation |
| 05/10/2013 | CA2848061A1 Use of human papillomavirus status in the treatment of cancer |
| 05/09/2013 | US20130117871 Human Antibodies Derived from Immunized Xenomice |
| 05/09/2013 | US20130116525 Analyte Monitoring Device and Methods of Use |
| 05/09/2013 | US20130116409 Method for Enriching Methylated CpG Sequences |
| 05/09/2013 | US20130116343 Salivary Protein Markers for Detection of Breast Cancer |
| 05/09/2013 | US20130116335 Method for identifying therapeutic agents for treatment of cancer |
| 05/09/2013 | US20130116167 Anti-mart-1 t cell receptors and related materials and methods of use |
| 05/09/2013 | US20130116166 Biomarkers for idiopathic pulmonary fibrosis |
| 05/09/2013 | US20130116152 Ubiquitination assay |
| 05/09/2013 | US20130116151 Biomarker for hypertensive disorders of pregnancy |
| 05/09/2013 | US20130116150 Lung Cancer Biomarkers and Uses Thereof |
| 05/09/2013 | US20130116148 Liver disease marker, method and apparatus for measuring the same, and method for assaying pharmaceutical preparation |
| 05/09/2013 | US20130116146 Peptide Microarray and Method of Use |
| 05/09/2013 | US20130116145 Diagnosis and prognosis of breast cancer patients |
| 05/09/2013 | US20130116142 Methods and materials for the diagnosis of prostate cancers |
| 05/09/2013 | US20130116140 Methods and materials for determining the efficacy of prostate cancer therapies |
| 05/09/2013 | US20130116137 Cantilevered probe detector with piezoelectric element |
| 05/09/2013 | US20130116135 Methods, Kits and Reagents for Diagnosing, Alding Diagnosis and/or Monitoring Progression of a Neurological Disorder |
| 05/09/2013 | US20130116134 Method and kit for the classification and prognosis of wounds |
| 05/09/2013 | US20130115718 Carrier Carrying Identifying Information for Identifying an Identification Subject and Use Thereof |
| 05/09/2013 | US20130115717 Analyzing chemical and biological substances using nano-structure based spectral sensing |
| 05/09/2013 | US20130115716 Methods of determining amyloid beta turnover in blood |
| 05/09/2013 | US20130115714 Western blot analytical technique |
| 05/09/2013 | US20130115713 Quantum dot-based optical sensors for rapid detection and quantitative analysis of biomolecules and biological materials |
| 05/09/2013 | US20130115706 Selective chemosensors based on the ferroelectric materials, mixed oxides, or temperature modulation of oxide polymorph stability |
| 05/09/2013 | US20130115704 System and method for the analysis of biodiesel |
| 05/09/2013 | US20130115687 Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of dna |
| 05/09/2013 | US20130115685 Point-of-care fluidic systems and uses thereof |
| 05/09/2013 | US20130115675 Dehalogenases, Nucleic Acids Encoding Them and Methods for Making and Using Them |
| 05/09/2013 | US20130115650 Isotopic Biomarkers for Rapid Assessment of Bone Mineral Balance in Biomedical Applications |
| 05/09/2013 | US20130115640 ACTH for Treatment of Kidney Disease |
| 05/09/2013 | US20130115639 Method for detecting a salmonella infection |
| 05/09/2013 | US20130115638 Method and rapid test for determining the fertility of sperm |
| 05/09/2013 | US20130115637 Efficiency of Prion Conversion in vitro and Sensitivity of Prion Detection |
| 05/09/2013 | US20130115636 Histone citrullinated peptides and uses thereof |
| 05/09/2013 | US20130115634 Peptides and methods for the detection of lyme disease antibodies |
| 05/09/2013 | US20130115633 Methods & Devices for Diagnosing Cardiac Disorders |
| 05/09/2013 | US20130115632 Highly sensitive method for assaying troponin i |
| 05/09/2013 | US20130115631 Methods For Measuring High Molecular Weight Complexes Of Fibrinogen With Fibronectin And Fibulin-1 |
| 05/09/2013 | US20130115630 Automated multiplex immunoassay |
| 05/09/2013 | US20130115629 Methods of breast cancer detection |
| 05/09/2013 | US20130115628 Method for selection of chemotherapeutic agents for adenocarcinoma cancer |
| 05/09/2013 | US20130115627 Methods for identifying candidate cytotoxic antibody molecules |
| 05/09/2013 | US20130115624 Methods To Identify Modulators |
| 05/09/2013 | US20130115623 Use of markers of undifferentiated pluripotent stem cells |
| 05/09/2013 | US20130115622 Pharmaceutical composition for prevention and treatment of amyotrophic lateral sclerosis |
| 05/09/2013 | US20130115621 Highly sensitive immunoassays and antibodies for detection of blood factor viii |
| 05/09/2013 | US20130115619 Ubiquitination assay |
| 05/09/2013 | US20130115618 Phospholipid profiling and cancer |
| 05/09/2013 | US20130115617 Methods of cell culture for adoptive cell therapy |
| 05/09/2013 | US20130115615 Method of classifying human subjects having adolescent idiopathic scoliosis (ais) and method for screening for a compound useful in the treatment of ais and related syndromes causing spinal deformities |
| 05/09/2013 | US20130115614 Method for detecting and quantifying endogenous wheat dna sequence |
| 05/09/2013 | US20130115613 Screening assays based on mag and/or abhd6 for selecting insulin secretion promoting agent |
| 05/09/2013 | US20130115612 Method for analyzing mucin 1 having siaalpha2-8siaalpha2-3galbeta glycans |
| 05/09/2013 | US20130115609 Methods and Kits for Detecting Circulating Cancer Stem Cells |
| 05/09/2013 | US20130115604 Methods and materials for the diagnosis of prostate cancers |
| 05/09/2013 | US20130115603 Nucleotide repeat expansion-associated polypeptides and uses thereof |
| 05/09/2013 | US20130115602 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 05/09/2013 | US20130115599 Increased cip2a expression and bladder cancer in humans |
| 05/09/2013 | US20130115295 Rare Earth-Doped Up-Conversion Nanoparticles for Therapeutic and Diagnostic Applications |